NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0960
-0.0040 (-4.00%)
Mar 4, 2026, 3:14 PM AEST

ASX:NSB Statistics

Total Valuation

ASX:NSB has a market cap or net worth of AUD 33.26 million. The enterprise value is 26.90 million.

Market Cap33.26M
Enterprise Value 26.90M

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date Feb 25, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:NSB has 332.58 million shares outstanding. The number of shares has increased by 64.61% in one year.

Current Share Class 332.58M
Shares Outstanding 332.58M
Shares Change (YoY) +64.61%
Shares Change (QoQ) +127.75%
Owned by Insiders (%) 9.29%
Owned by Institutions (%) 3.17%
Float 241.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 104.61
PB Ratio 2.02
P/TBV Ratio 5.22
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -8.47
EV / Sales 84.62
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 31.62

Current Ratio 31.62
Quick Ratio 31.14
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5,884.84

Financial Efficiency

Return on equity (ROE) is -29.65% and return on invested capital (ROIC) is -19.63%.

Return on Equity (ROE) -29.65%
Return on Assets (ROA) -19.42%
Return on Invested Capital (ROIC) -19.63%
Return on Capital Employed (ROCE) -20.46%
Weighted Average Cost of Capital (WACC) 10.96%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.03
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +163.16% in the last 52 weeks. The beta is 1.22, so ASX:NSB's price volatility has been higher than the market average.

Beta (5Y) 1.22
52-Week Price Change +163.16%
50-Day Moving Average 0.12
200-Day Moving Average 0.13
Relative Strength Index (RSI) 31.39
Average Volume (20 Days) 139,903

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:NSB had revenue of AUD 317,905 and -3.18 million in losses. Loss per share was -0.01.

Revenue317,905
Gross Profit 271,313
Operating Income -3.37M
Pretax Income -3.18M
Net Income -3.18M
EBITDA -2.70M
EBIT -3.37M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 6.36 million in cash and n/a in debt, with a net cash position of 6.36 million or 0.02 per share.

Cash & Cash Equivalents 6.36M
Total Debt n/a
Net Cash 6.36M
Net Cash Per Share 0.02
Equity (Book Value) 16.45M
Book Value Per Share 0.05
Working Capital 6.37M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.39M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 85.34%
Operating Margin -1,058.85%
Pretax Margin -999.47%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ASX:NSB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -64.61%
Shareholder Yield -64.61%
Earnings Yield -9.55%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:NSB has an Altman Z-Score of 88.89 and a Piotroski F-Score of 1.

Altman Z-Score 88.89
Piotroski F-Score 1